Search results (6)
« Back to NewsUniversity of Oxford team secures major grant to investigate Bipolar Disorder
26 September 2024
A team led by Paul Harrison in the Department of Psychiatry has been awarded a BD²: Breakthrough Discoveries grant to look at the role of voltage-gated calcium channels in Bipolar Disorder.
Prioritising the children of parents with severe mental illness
24 July 2023
Bipolar Disorder Child and Adolescent Psychiatry Child and adolescent Schizophrenia
The needs of children whose parents have severe mental illness should be prioritised, according to a new paper written by a consortium of international experts.
£3 million legacy gift to deliver significant benefits for people with bipolar disorder
30 March 2023
Research into bipolar disorder at Oxford has received a major boost following a £3 million donation from the Page family.
New study reveals clinical instability can predict psychiatric hospitalisation
28 March 2023
Bipolar Disorder Depression Mental Health Schizophrenia
For patients with psychiatric conditions, data shows that both illness severity and instability are key factors in predicting their future risk of hospitalisation.
Improved Risk Estimation of Bipolar Spectrum Disorders in Adolescent Offspring of Bipolar Parents
2 September 2021
Bipolar Disorder Mental Health
This new study using Canadian and Swiss data showed that the risk calculator used to predict the likelihood of developing a major mood disorder was correct approximately 70% of the time. The study results suggest this may be a useful clinical tool in routine practice for improved individualised risk estimation of bipolar spectrum disorders among the adolescent offspring of a parent with a bipolar disorder.
New Phase 2 Bipolar Disorder Study with Ebselen (SPI-1005)
21 September 2020
Bipolar Disorder Mental Health
The University of Oxford and Sound Pharmaceuticals completed this new Phase 2a study testing SPI-1005, an investigational drug that contains ebselen, as a new treatment for bipolar disorder.